2817
OBSERVATIONS: A 48-year-old woman presented with disfiguring facial edema 10 weeks after she began antiviral therapy with peginterferon alfa-2a and ribavirin for chronic hepatitis C infection.
 A 48-year-old woman: Subject; 48-year-old: Subject.Age; woman: Subject.Gender; disfiguring facial edema: Effect; 10 weeks: Treatment; antiviral therapy with peginterferon alfa-2a and ribavirin: Treatment; chronic hepatitis C infection: Treatment.Disorder; 10 weeks: Treatment.Time_elapsed; peginterferon alfa-2a: Treatment.Drug; ribavirin: Treatment.Drug; peginterferon alfa-2a: Combination.Drug; ribavirin: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 A 48-year-old woman: Subject; 48-year-old: Subject.Age; woman: Subject.Gender; disfiguring facial edema: Effect; 10 weeks: Treatment; antiviral therapy with peginterferon alfa-2a and ribavirin: Treatment; chronic hepatitis C infection: Treatment.Disorder; 10 weeks: Treatment.Time_elapsed; peginterferon alfa-2a: Treatment.Drug; ribavirin: Treatment.Drug; peginterferon alfa-2a: Combination.Drug; ribavirin: Combination.Drug